-
1
-
-
0018547288
-
Exposure of platelet fibrinogen receptors by ADP and epinephrine
-
Bennett JS, Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 1979; 64: 1393-401.
-
(1979)
J. Clin. Invest.
, vol.64
, pp. 1393-1401
-
-
Bennett, J.S.1
Vilaire, G.2
-
2
-
-
0018758931
-
Human platelets possess an inducible and saturable receptor specific for fibrinogen
-
Marguerie GA, Plow EF, Edgington TS. Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem 1979; 254: 5357-63.
-
(1979)
J. Biol. Chem.
, vol.254
, pp. 5357-5363
-
-
Marguerie, G.A.1
Plow, E.F.2
Edgington, T.S.3
-
4
-
-
0018129207
-
A two-step fibrinogen-fibrin transition in blood coagulation
-
Blombäck B, Hessel B, Hogg D et al. A two-step fibrinogen-fibrin transition in blood coagulation. Nature 1978; 275: 501-5.
-
(1978)
Nature
, vol.275
, pp. 501-505
-
-
Blombäck, B.1
Hessel, B.2
Hogg, D.3
-
5
-
-
0035159395
-
Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin
-
Siebenlist KR, Meh D, Mosesson MW. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin. Thromb Haemost 2001; 86: 1221-8.
-
(2001)
Thromb. Haemost.
, vol.86
, pp. 1221-1228
-
-
Siebenlist, K.R.1
Meh, D.2
Mosesson, M.W.3
-
6
-
-
0016759666
-
Cross-linking of fibrinogen and fibrin by fibrin-stabilizing factor (factor XIIIa)
-
Kanaide H, Shainuff JR. Cross-linking of fibrinogen and fibrin by fibrin-stabilizing factor (factor XIIIa). J Lab Clin Med 1975; 85: 574-97.
-
(1975)
J. Lab. Clin. Med.
, vol.85
, pp. 574-597
-
-
Kanaide, H.1
Shainuff, J.R.2
-
7
-
-
0032513756
-
Association of fibrinogen, C-reactive protein, albumin, Or leukocyte count with coronary heart disease
-
Danesh J, Collins R, Appleby P et al. Association of fibrinogen, C-reactive protein, albumin, Or leukocyte count with coronary heart disease. JAMA 1998; 279: 1477-82.
-
(1998)
JAMA
, vol.279
, pp. 1477-1482
-
-
Danesh, J.1
Collins, R.2
Appleby, P.3
-
8
-
-
0034969115
-
Fibrinogen and its degradation products as thrombotic risk factors
-
Lowe GD, Rumley A. Fibrinogen and its degradation products as thrombotic risk factors. Ann NY Acad Sci 200l; 936: 560-5.
-
(2001)
Ann. NY Acad. Sci.
, vol.936
, pp. 560-565
-
-
Lowe, G.D.1
Rumley, A.2
-
9
-
-
0028342850
-
Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms - The Leiden Thrombophilia Study (LETS)
-
Koster T, Rosendaal FR, Reitsma PH et al. Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms-the Leiden Thrombophilia Study (LETS). Thromb Haemost 1994; 71: 719 22.
-
(1994)
Thromb. Haemost.
, vol.71
, pp. 719-722
-
-
Koster, T.1
Rosendaal, F.R.2
Reitsma, P.H.3
-
10
-
-
1542544882
-
High levels of fibrinogen are associated with the risk of deep venous thrombosis mainly in the elderly
-
van Hylckama Vlieg A, Rosendaal FR. High levels of fibrinogen are associated with the risk of deep venous thrombosis mainly in the elderly. J Thromb Haemost 2003; 1: 2677-8.
-
(2003)
J. Thromb. Haemost.
, vol.1
, pp. 2677-2678
-
-
van Hylckama Vlieg, A.1
Rosendaal, F.R.2
-
11
-
-
0022339326
-
A model for fibrinogen: Domains and sequence
-
Weisel JW, Stauffacher CV, Bullitt E et al. A model for fibrinogen: Domains and sequence. Science 1985; 230: 1388-91.
-
(1985)
Science
, vol.230
, pp. 1388-1391
-
-
Weisel, J.W.1
Stauffacher, C.V.2
Bullitt, E.3
-
12
-
-
0141450410
-
Fibrinogen γ-chain functions
-
Mosesson MW Fibrinogen γ-chain functions. J Thromb Haemost 2003; 1: 231-8.
-
(2003)
J. Thromb. Haemost.
, vol.1
, pp. 231-238
-
-
Mosesson, M.W.1
-
13
-
-
0041355237
-
Identification of a novel binding site for platelet integrin αIIbβ3 (GPIIb/IIIa) and α5β1 in the γC-domain of fibrinogen
-
Podolnikova NP, Yakubenko VP, Volkov GL et al. Identification of a novel binding site for platelet integrin αIIbβ3 (GPIIb /IIIa) and α5β1 in the γC-domain of fibrinogen. J Biol Chem 2003; 278: 32251-58.
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 32251-32258
-
-
Podolnikova, N.P.1
Yakubenko, V.P.2
Volkov, G.L.3
-
14
-
-
0029124978
-
A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin
-
Taubenfeld SM, Song Y, Sheng D et al. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin. Thromb Haemost 1995; 74: 923-7.
-
(1995)
Thromb. Haemost.
, vol.74
, pp. 923-927
-
-
Taubenfeld, S.M.1
Song, Y.2
Sheng, D.3
-
15
-
-
0034762541
-
A hamster antibody to the mouse fibrinogen γ chain inhibits platelet-fibrinogen interactions and FXIIIa-mediated fibrin cross-linking, and facilitate thrombolysis
-
Jiroušková M, Smyth SS, Kudryk B et al. A hamster antibody to the mouse fibrinogen γ chain inhibits platelet-fibrinogen interactions and FXIIIa-mediated fibrin cross-linking, and facilitate thrombolysis. Thromb Haemost 2001; 86: 1047-56.
-
(2001)
Thromb. Haemost.
, vol.86
, pp. 1047-1056
-
-
Jiroušková, M.1
Smyth, S.S.2
Kudryk, B.3
-
16
-
-
1542308213
-
A monoclonal antibody to the fibrinogen 7-chain alters fibrin clot structure and its properties by producing short, thin fibers arranged in bundles
-
Schemer T, Jiroušková M, Nagaswami C et al. A monoclonal antibody to the fibrinogen 7-chain alters fibrin clot structure and its properties by producing short, thin fibers arranged in bundles. J Thromb Haemost 2003;1: 2594-602.
-
(2003)
J. Thromb. Haemost.
, vol.1
, pp. 2594-2602
-
-
Schemer, T.1
Jiroušková, M.2
Nagaswami, C.3
-
17
-
-
1542373667
-
Antibody blockade or mutation of the fibrinogen γ-chain C-terminus is more effective in inhibiting murine arterial thrombus formation than complete absence of fibrinogen
-
Jiroušková M, Chereshnev I, Väänänen H et al. Antibody blockade or mutation of the fibrinogen γ-chain C-terminus is more effective in inhibiting murine arterial thrombus formation than complete absence of fibrinogen. Blood 2004; 103: 1995-2002.
-
(2004)
Blood
, vol.103
, pp. 1995-2002
-
-
Jiroušková, M.1
Chereshnev, I.2
Väänänen, H.3
-
18
-
-
0032436996
-
Surface protein adhesins of Staphylococcus aureus
-
Foster TJ, Höök M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol 1998; 6: 484-8.
-
(1998)
Trends Microbiol.
, vol.6
, pp. 484-488
-
-
Foster, T.J.1
Höök, M.2
-
19
-
-
0020060170
-
Identification of a region of human fibrinogen interacting with staphylococcal clumping factor
-
Hawiger JS, Timmons S, Strong DD et al. Identification of a region of human fibrinogen interacting with staphylococcal clumping factor. Biochemistry 1982; 21: 1407-13.
-
(1982)
Biochemistry
, vol.21
, pp. 1407-1413
-
-
Hawiger, J.S.1
Timmons, S.2
Strong, D.D.3
-
20
-
-
0028334112
-
Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus
-
McDevitt D, Francois P, Vaudaux P et al. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol 1994; 11: 237-48.
-
(1994)
Mol. Microbiol.
, vol.11
, pp. 237-248
-
-
McDevitt, D.1
Francois, P.2
Vaudaux, P.3
-
21
-
-
0030758696
-
Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen
-
McDevitt D, Nanavaty T, House-Pompeo K et al. Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen. Eur J Biochem 1997; 247: 416-24.
-
(1997)
Eur. J. Biochem.
, vol.247
, pp. 416-424
-
-
McDevitt, D.1
Nanavaty, T.2
House-Pompeo, K.3
-
22
-
-
12244313428
-
A novel variant ofthe immunoglobulin fold in surface adhesions of Staphylococcus aureus: Crystal structure of the fibrinogen-binding MSCRAMM, clumping factor A
-
Deivanayagam CC, Wann ER, Chen W et al. A novel variant ofthe immunoglobulin fold in surface adhesions of Staphylococcus aureus: crystal structure of the fibrinogen-binding MSCRAMM, clumping factor A. EMBO 2002; 21: 6660-72.
-
(2002)
EMBO
, vol.21
, pp. 6660-6672
-
-
Deivanayagam, C.C.1
Wann, E.R.2
Chen, W.3
-
23
-
-
0031568217
-
Crovidisin, a collagen-binding protein isolated from snake venom of Crotalus viridis, prevents platelet-collagen interaction
-
Liu C-Z, Huang T-F. Crovidisin, a collagen-binding protein isolated from snake venom of Crotalus viridis, prevents platelet-collagen interaction. Arch Biochem Biophys 1997; 337: 291-9.
-
(1997)
Arch. Biochem. Biophys.
, vol.337
, pp. 291-299
-
-
Liu, C.-Z.1
Huang, T.-F.2
-
24
-
-
0028267193
-
A colorimetric method for the measurement of platelet adhesion in microtilter plates
-
Bellavite P, Andrioli G, Guzzo P et al. A colorimetric method for the measurement of platelet adhesion in microtilter plates. Anal Chem 1994; 216: 444-50.
-
(1994)
Anal. Chem.
, vol.216
, pp. 444-450
-
-
Bellavite, P.1
Andrioli, G.2
Guzzo, P.3
-
25
-
-
0037087234
-
Trimucytin, a collagen-like snake venom protein, activates platelets independent of I-domain within α2 subunit of α2β1 integrin
-
Liu C-Z, Wu T-F, Huang T-F et al. Trimucytin, a collagen-like snake venom protein, activates platelets independent of I-domain within α2 subunit of α2β1 integrin. Thromb Res 2002; 105: 153-60.
-
(2002)
Thromb. Res.
, vol.105
, pp. 153-160
-
-
Liu, C.-Z.1
Wu, T.-F.2
Huang, T.-F.3
-
26
-
-
0025880046
-
Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist
-
Huang T-F, Liu C-Z, Ouyang C et al. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist. Biochem Pharmacol 1991; 42: 1209-19.
-
(1991)
Biochem. Pharmacol.
, vol.42
, pp. 1209-1219
-
-
Huang, T.-F.1
Liu, C.-Z.2
Ouyang, C.3
-
27
-
-
0028610549
-
Analysis of human platelet glycoprotein IIb-IIIa by fluorescein isothiocyanate-conjugated disintegrins with flow cytometry
-
Liu C-Z, Wang Y-W, Shen M-C et al. Analysis of human platelet glycoprotein IIb-IIIa by fluorescein isothiocyanate-conjugated disintegrins with flow cytometry. Thromb Haemost 1994; 72: 919-25.
-
(1994)
Thromb. Haemost.
, vol.72
, pp. 919-925
-
-
Liu, C.-Z.1
Wang, Y.-W.2
Shen, M.-C.3
-
28
-
-
0030998485
-
The conversation of fibrinogen to fibrin: Recombinant fibrinogen typifies plasma fibrinogen
-
Gorkun OV, Veklich YI, Weisel YW et al. The conversation of fibrinogen to fibrin: recombinant fibrinogen typifies plasma fibrinogen. Blood 1997; 89: 4407-14.
-
(1997)
Blood
, vol.89
, pp. 4407-4414
-
-
Gorkun, O.V.1
Veklich, Y.I.2
Weisel, Y.W.3
-
29
-
-
0032520709
-
Inhibition of platelet-mediated clot retraction by integrin antagonists
-
Hantgan RR, Mousa SA. Inhibition of platelet-mediated clot retraction by integrin antagonists. Thromb Res 1998; 89: 271-9.
-
(1998)
Thromb. Res.
, vol.89
, pp. 271-279
-
-
Hantgan, R.R.1
Mousa, S.A.2
-
30
-
-
0020619733
-
A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoprotein IIb and/or IIIa
-
Coller BS, Peerschke EI, Scudder LE et al. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoprotein IIb and/or IIIa. J Clin Invest 1983; 72: 325-38.
-
(1983)
J. Clin. Invest.
, vol.72
, pp. 325-338
-
-
Coller, B.S.1
Peerschke, E.I.2
Scudder, L.E.3
-
31
-
-
19344365899
-
Blockade of glycoprotein IIb/IIIa by crotavirin, a member of disintegrins, prevents platelet from activation and aggregation by Staphylococcus aureus bacteria
-
Liu C-Z, Huang H-Y, Tsai P-J et al. Blockade of glycoprotein IIb/IIIa by crotavirin, a member of disintegrins, prevents platelet from activation and aggregation by Staphylococcus aureus bacteria. Thromb Res 2005; 116: 145-55.
-
(2005)
Thromb. Res.
, vol.116
, pp. 145-155
-
-
Liu, C.-Z.1
Huang, H.-Y.2
Tsai, P.-J.3
-
33
-
-
0015523406
-
Human fibrinogen heterogeneities. III. Identification of γ chain variants
-
Mosesson MW, Finlayson JS, Umfleet RA. Human fibrinogen heterogeneities. III. Identification of γ chain variants. J Biol Chem 1972; 247: 5223-7.
-
(1972)
J. Biol. Chem.
, vol.247
, pp. 5223-5227
-
-
Mosesson, M.W.1
Finlayson, J.S.2
Umfleet, R.A.3
-
34
-
-
0028052961
-
Binding of recombinant fibrinogen mutants to platelets
-
Farrell DH, Thiagarajan P. Binding of recombinant fibrinogen mutants to platelets. J Biol Chem 1994; 269: 226-31.
-
(1994)
J. Biol. Chem.
, vol.269
, pp. 226-231
-
-
Farrell, D.H.1
Thiagarajan, P.2
-
35
-
-
0019769991
-
Carboxy-terminal amino acid sequence of a human fibrinogen γ chain variant (γ')
-
Wolfenstein-Todel C, Mosesson MW Carboxy-terminal amino acid sequence of a human fibrinogen γ chain variant (γ'). Biochemistry 1981; 20: 6146-9.
-
(1981)
Biochemistry
, vol.20
, pp. 6146-6149
-
-
Wolfenstein-Todel, C.1
Mosesson, M.W.2
-
36
-
-
0021868360
-
Platelets interact with fibrin only after activation
-
Hantgan RR, Taylor RG, Lewis JC. Platelets interact with fibrin only after activation. Blood 1985; 65: 1299-311.
-
(1985)
Blood
, vol.65
, pp. 1299-1311
-
-
Hantgan, R.R.1
Taylor, R.G.2
Lewis, J.C.3
-
37
-
-
0023878246
-
Localization of the domains of fibrin involved in binding to platelets
-
Hantgan RR. Localization of the domains of fibrin involved in binding to platelets. Biochim Biophys Acta 1988; 968: 36-44.
-
(1988)
Biochim. Biophys. Acta
, vol.968
, pp. 36-44
-
-
Hantgan, R.R.1
-
38
-
-
0020312395
-
Ultastructure of clots during isometric contraction
-
Cohen I, Gerrard JM, White JG. Ultastructure of clots during isometric contraction. J Cell Biol 1982; 93: 775-87.
-
(1982)
J. Cell Biol.
, vol.93
, pp. 775-787
-
-
Cohen, I.1
Gerrard, J.M.2
White, J.G.3
|